Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer

Lee, CK; Scott, C; Lindeman, GJ; Hamilton, A; Lieschke, E; Gibbs, E; Asher, R; Badger, H; Paterson, R; Macnab, L; Kwan, EM; Francis, PA; Boyle, F; Friedlander, M

Lee, CK (reprint author), St George Hosp, Sydney, NSW, Australia.; Lee, CK (reprint author), NHMRC, Clin Trials Ctr, Sydney, NSW, Australia.

BRITISH JOURNAL OF CANCER, 2019; 120 (3): 279

Abstract

BACKGROUND: We conducted a Phase 1 study to evaluate safety and activity of olaparib tablets and oral cyclophosphamide. METHODS: Patients had metastat......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索